Topics

Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Revision: 1, Authorised

05:15 EST 2 Feb 2018 | European Medicines Agency
This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Revision: 1, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Revision: 1, Authorised"

Quick Search